BMS — —
  • 恒瑞医药与BMS达成全球重磅合作，港股涨超14%、A股涨超6%

    恒瑞医药与百时美施贵宝（BMS）达成全球战略合作，共同开发13款早期创新药。受此消息提振，恒瑞医药港股单日涨幅超14%，A股涨幅超6%，创近期最大单日涨幅。技术面上，股价突破关键阻力位，成交量显著放大，机构资金净流入明显。这一合作被视为中国创新药企与全球制药巨头深度绑定的标志性事

📊 在监控面板里跟踪 BMS —— 添加到 watchlist，配合价格 + 舆情双触发的告警规则，命中即时通过 Telegram / 邮件推送。

🗂️ All Tools

RedianPro one-stop tool index — 22 dedicated function pages. Data auto-refreshes every 30 min to 1 hour.

📋BriefingTonight's pre-market read📰Daily WrapWhat happened today🌡️Sectors11 SPDR sector ETFs📅Earnings14d earnings + FOMC📝InsidersSEC Form 4 ≥ $1M🏛️Fed MacroFOMC + Fed speeches📈Yield Curve11 tenors + inversion📊CFTC COTHedge fund positioning₿Crypto12 coins + Fear/Greed⛽CommoditiesGold / Oil / Ag🐉China ADRsADR ⇆ HK arb🔥WSB HeatRetail social Top 50🏆LeaderboardMost-watched tickers🚀52w HighMomentum signals📉52w LowReversal candidates🔎ScreenerMulti-dim filter⚖️Compare30 metrics side-by-side🧮CalculatorsDCF / IV / Sharpe🤖AI Q&ANatural language query🔍SearchSite-wide search📚Glossary100+ EN-CN terms📈PortfolioClient-side simulator📑NewsDaily Chinese digest